Ironwood Pharmaceuticals, Inc. (IRWD)
3.64
-0.12
(-3.19%)
USD |
NASDAQ |
Oct 02, 16:00
3.64
0.00 (0.00%)
After-Hours: 20:00
Ironwood Pharmaceuticals Max Drawdown (5Y) : 96.33% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 96.33% |
| August 31, 2026 | 96.33% |
| July 31, 2026 | 96.33% |
| June 30, 2026 | 96.33% |
| May 31, 2026 | 96.33% |
| April 30, 2026 | 96.33% |
| March 31, 2026 | 96.33% |
| February 28, 2026 | 96.33% |
| January 31, 2026 | 96.33% |
| December 31, 2025 | 96.33% |
| November 30, 2025 | 96.33% |
| October 31, 2025 | 96.33% |
| September 30, 2025 | 96.33% |
| August 31, 2025 | 96.33% |
| July 31, 2025 | 96.33% |
| June 30, 2025 | 96.33% |
| May 31, 2025 | 96.33% |
| April 30, 2025 | 95.81% |
| March 31, 2025 | 90.87% |
| February 28, 2025 | 89.58% |
| January 31, 2025 | 85.11% |
| December 31, 2024 | 78.38% |
| November 30, 2024 | 78.38% |
| October 31, 2024 | 74.56% |
| September 30, 2024 | 74.56% |
| Date | Value |
|---|---|
| August 31, 2024 | 73.79% |
| July 31, 2024 | 63.88% |
| June 30, 2024 | 63.88% |
| May 31, 2024 | 61.94% |
| April 30, 2024 | 53.39% |
| March 31, 2024 | 53.39% |
| February 29, 2024 | 53.39% |
| January 31, 2024 | 53.39% |
| December 31, 2023 | 53.39% |
| November 30, 2023 | 55.81% |
| October 31, 2023 | 55.81% |
| September 30, 2023 | 55.81% |
| August 31, 2023 | 55.81% |
| July 31, 2023 | 55.81% |
| June 30, 2023 | 55.81% |
| May 31, 2023 | 55.81% |
| April 30, 2023 | 55.81% |
| March 31, 2023 | 55.81% |
| February 28, 2023 | 55.81% |
| January 31, 2023 | 55.81% |
| December 31, 2022 | 55.81% |
| November 30, 2022 | 55.81% |
| October 31, 2022 | 55.81% |
| September 30, 2022 | 55.81% |
| August 31, 2022 | 55.81% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Viking Therapeutics, Inc. | 89.26% |
| Inovio Pharmaceuticals, Inc. | 99.62% |
| MediciNova, Inc. | 90.32% |
| Rigel Pharmaceuticals, Inc. | 86.40% |
| AbbVie, Inc. | 21.89% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -27.13 |
| Beta (5Y) | 0.2154 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 79.82% |
| Historical Sharpe Ratio (5Y) | -0.3129 |
| Historical Sortino (5Y) | -0.5492 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 35.33% |